BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome

BioLight announced today that it has obtained the worldwide rights (excluding Israel and Italy) for the manufacturing, distribution, marketing and sales of a groundbreaking new eye drop product for the treatment of dry eye syndrome (DES) and other ophthalmic indications.

Link to complete article

Link to Newsroom

Comments are closed.